Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPI Pharma is a leading global provider of specialty excipients, drug delivery systems, and antacid active ingredients for the pharmaceutical and nutritional industries. The company specializes in helping pharmaceutical manufacturers solve formulation challenges, particularly in the development of patient-friendly dosage forms such as orally disintegrating tablets (ODTs) and chewables. SPI Pharma also provides comprehensive technical services and contract development and manufacturing (CDMO) solutions to accelerate product speed-to-market. As a subsidiary of Associated British Foods, the company maintains a significant global footprint with manufacturing and innovation centers in the United States, France, and India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPI.